Table 2.

Association of immunosuppressant utilization with NODALT

Immunosuppressant	Recipients without NODALT (n=1,951)		Recipients with NODALT (n=189)		p-value
Cyclosporine (CsA)	363	(18.61%)	36	(19.05%)	0.8816
Tacrolimus (TAC)	1,691	(86.67%)	181	(95.77%)	0.0003*
Mycophenolate mofetil (MMF)	1,472	(75.45%)	156	(82.54%)	0.0291*
Sirolimus	376	(19.27%)	40	(21.16%)	0.5303
Everolimus	165	(8.46%)	13	(6.88%)	0.4529

Notes: Immunosuppressant utilization was defined as the presence of drug code in more than 10% of the total immunosuppressant prescriptions. Tacrolimus and mycophenolate mofetil had significant correlations with the incidence of NODALT;

^*p<0.05.

Abbreviation: NODALT, new-onset diabetes after liver transplantation.